In 2020, as scientists around the world were racing to understand COVID-19, Prof. Roy Bar-Ziv and his team at the Weizmann Institute of Science started developing a DNA chip that could not only ...
In recent years, the measurement of multiple proteins as disease signatures or biomarkers from patient samples has risen rapidly as an enabling tool for the pharmaceutical and diagnostics industries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback